FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 144 filers reported holding FIBROGEN INC in Q1 2017. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $475,000 | -50.7% | 11,072 | -57.5% | 0.16% | -50.0% |
| Q3 2019 | $964,000 | -18.2% | 26,072 | 0.0% | 0.32% | -34.0% |
| Q2 2019 | $1,178,000 | -16.9% | 26,072 | 0.0% | 0.48% | -20.0% |
| Q1 2019 | $1,417,000 | +17.4% | 26,072 | 0.0% | 0.60% | +2.6% |
| Q4 2018 | $1,207,000 | -23.8% | 26,072 | 0.0% | 0.58% | -23.2% |
| Q3 2018 | $1,584,000 | -2.9% | 26,072 | 0.0% | 0.76% | -11.2% |
| Q2 2018 | $1,632,000 | +13.6% | 26,072 | -16.1% | 0.86% | -0.2% |
| Q1 2018 | $1,436,000 | -2.5% | 31,072 | 0.0% | 0.86% | +10.3% |
| Q4 2017 | $1,473,000 | -11.9% | 31,072 | 0.0% | 0.78% | -34.9% |
| Q3 2017 | $1,672,000 | +66.5% | 31,072 | 0.0% | 1.20% | +63.8% |
| Q2 2017 | $1,004,000 | +31.1% | 31,072 | 0.0% | 0.73% | +31.8% |
| Q1 2017 | $766,000 | – | 31,072 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |